Phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. - Buzdar,A.; Jones,S.; Vogel,C. (Cancer, 1997)